Search

everythinglearnresearchcommunity

for

Search:↓

Continuing education programs significantly increased rural nurse practitioners' knowledge about PCOS.

Myo-inositol and D-chiro-inositol improve hormonal and physical symptoms in teenage girls with PCOS.

Review finds no permanent solution for female hair loss.

Review determines effective, safe treatments for female hair loss.

Larger ovaries in women with PCOS may indicate higher insulin resistance.

Telogen Effluvium (TE) significantly affects women due to stress and hormonal changes, requiring better public health policies and mental health support.

Ovol2 is crucial for hair growth and skin healing by controlling cell movement and growth.

Early hair loss may indicate risk of insulin resistance.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Metabolic syndrome reduces effectiveness of hair loss treatment.

Get head MRI for babies with achondroplasia early, use free immunoglobulin light chains to detect certain neurodevelopmental disorders, and video calls work for speech therapy in patients with facial anomalies.

Women with prediabetes may have a higher risk of PCOS-like changes, especially if they have impaired glucose tolerance.

Many adults in Porto have acne, but few know or treat it.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Cyproterone acetate-estrogen most effective for hirsutism, but consider side effects and patient needs.

Metformin improves hair growth and menstrual frequency in women with PCOS and hirsutism.

Spironolactone effectively reduces hair growth in women with hirsutism and is generally well-tolerated.

Finasteride reduces hair growth better, but spironolactone has more side effects.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.